Image-based biomarker detection for real-world precision medicine

Rectangle 54-2

Our Mission

Imagene's mission is to assist cancer patients in receiving the optimal treatment medicine can offer by leveraging AI to detect, in real-time, a broad range of cancerous biomarkers and genomic insights directly from the biopsy image.

We overcome economical, logistical, and technological barriers to reach the full potential of precision medicine for cancer patients.

Read More

A New Standard for Biomarker DetectionFrom 14 days to 2 minutes

Making genomic testing accessible, leveraging the biopsy image for research and treatment optimization

Schedule a demo
bg-home-demo

Imagene for Research

Standardize, accelerate and reduce costs of drug development through deep learning for clinical trials

noto_test-tube

Clinical Trials

noto_microscope

Precision Oncology

noto_pill

Drug Development

Imagene for Clinical

Supporting clinical decision-making by providing clinicians with a real-time molecular report using only the scanned image of an H&E-stained biopsy slide

icon-real-time-diagnosis

Real-time Diagnosis

icon-image-only

Image Only (no tissue required)

icon-accuracy-levels

Accuracy levels of diagnostic tests

icon-optimized-treatment-plans

Optimized treatment plans

vector-home-clinical

Imagene in Numbers

Organs

Group 5

Models

Group 6
%

avg Sensitivity

Group 7
%

avg Specificity

Group 8
bg-home-numbers
img-technology

Our Technology

lmagene's state-of-the-art deep learning models have the capabilities of searching for all present phenotypic alterations and empowering the reporting of meaningful insights.

We make no assumptions. our models rely on prospective data and unsupervised learning to provide the highest sensitivity and specificity rates.

Book a Demo

Join our Partners

logo-partners-1 logo-partners-2 logo-partners-3
Learn More About Us
vector-jhome-partners-1
vector-jhome-partners-2